This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Monocyte Activation Test

The monocyte activation test (MAT) was included in the European Pharmacopoeia (Ph Eur) in 2010. It is to detect substances that may have fever-inducing effects on humans.

Labor LS offers the monocyte activation test as an important complement to the LAL and pyrogen test because it detects not only endotoxins and has a similarly high sensitivity. On this basis, a broader range of preparations can be investigated than with the traditional pyrogen test. However, a product-specific development and validation is a prerequisite for the application of the test. 

Your contact person:

Dr rer nat Enrico Barth 
Graduate Biologist



LS opts for a future-oriented corporate structure

Press release dated 23 April 2018



26. Jahrestagung, Arbeitsgemeinschaft Radiochemie und Radiopharmazie, Klinik für Nuklearmedizin der Uniklinik Aachen

20. - 22.09.2018, Aachen (Universitätsklinikum der RWTH Aachen -Klinik für...

aseptiKon 2018

25./26. September 2018, Wiesbaden



Labor LS SE & Co. KG

Mangelsfeld 4, 5, 6
97708 Bad Bocklet-

Fon: +49 (0)9708/9100-0
Fax: +49 (0)9708/9100-36


In our Infobox, we make additional information on our company, our service portfolio and our QM certification available to you in a download.